Mesoblast | MSB - Debt

Stock Price
2.35
Daily Change
0.05 2.17%
Monthly
-11.32%
Yearly
-4.47%
Q1 Forecast
2.36

Mesoblast reported $118.92M in Debt for its fiscal semester ending in June of 2024.





Debt Change Date
Avita Medical AUD 44.59M 1.4M Jun/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Starpharma Holdings AUD 2.4M 73K Jun/2025
Telix Pharmaceuticals AUD 418.25M 163.2M Jun/2025